Alan Dove. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Behavior ControlDiabetes Mellitus/drug therapyDiabetes Mellitus/epidemiologyDiabetes Mellitus/therapyDiabetes Mellitus, Type 1/drug therapyDiabetes Mellitus, Type 2/drug therapyDietExerciseGlycoside Hydrolase InhibitorsHumansHypoglycemic Agents/classificationHypoglycemic Agents/therapeutic useInsulin/therapeutic useMetformin/therapeutic useObesitySulfonylurea Compounds/therapeutic useThiazoles/therapeutic useThiazolidinedionesTreatment OutcomeUnited States/epidemiology
Substances: See more » Glycoside Hydrolase InhibitorsHypoglycemic AgentsInsulinSulfonylurea CompoundsThiazolesThiazolidinedionesMetformin2,4-thiazolidinedione
Year: 2002 PMID: 12355109 DOI: 10.1038/nbt1002-977
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908